National Database of the Virtual Institute of Cerebrovascular Diseases
BIG-MENTI
1 other identifier
observational
285,600
1 country
1
Brief Summary
The primary aim of the study is to develop a national registry of cerebrovascular diseases in order to define the subtypes of these diseases associated with a worse prognosis. Secondly, the study aims to find clinical, radiological, and biological markers capable tof predicting the outcome of cerebrovascular diseases and the onset of complications related to therapeutic procedures, and to calculate predictive prognostic scores composed of multiple variables. Each participating center will collect clinical, radiological, and biological data from the medical records of the study participants. Patients included in the study will not undergo any additional medical procedures to those of normal clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2052
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2052
July 13, 2023
July 1, 2023
29 years
June 9, 2023
July 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Identification of subtypes of each cerebrovascular disease (ICD-9 430-438) associated with poor prognosis.
Identification and definition of the various subtypes of each cerebrovascular disease (International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438) associated with poor prognosis.
July 1, 2023 - July 1, 2053
Secondary Outcomes (20)
Identification of clinical variables of each cerebrovascular disease correlated with its prognosis
July 1, 2023 - July 1, 2053
Identification of radiological variables of each cerebrovascular disease correlated with its prognosis
July 1, 2023 - July 1, 2053
Identification of biomarkers of each cerebrovascular disease correlated with its prognosis
July 1, 2023 - July 1, 2053
Identification of neurophysiological variables of each cerebrovascular disease correlated with its prognosis
July 1, 2023 - July 1, 2053
Identification of prognostic scores for each cerebrovascular disease
July 1, 2023 - July 1, 2053
- +15 more secondary outcomes
Study Arms (1)
All patients with new-onset cerebrovascular disease from January 1, 2016 to July 1, 2049
Interventions
Collection of clinical, radiological, and biological data from patients' medical records
Eligibility Criteria
All patients with cerebrovascular diseases occuring between January 1, 2016 and July 1, 2049 who consented to partecipate in the study
You may qualify if:
- Diagnosis of cerebrovascular pathology defined according to the NINDS special report of 1990 as "all disorders in which there is an area of the brain transiently or permanently affected by ischemia or bleeding and/or in which one or more blood vessels of the brain are mainly altered by a pathological process", falling within the following codes of the International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438;
- Informed consent provided by the patient or his legal representative in the case of mental incapacity or by the parents/guardians in the case of minors.
You may not qualify if:
- The patient, his legal representative in the case of mental incapacity or his parents/guardians in the case of minors clearly state their will to leave the study;
- Onset of cerebrovascular disease before January 1, 2016.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Don Carlo Gnocchi Onluscollaborator
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSlead
- Humanitas Hospital, Italycollaborator
- IRCCS Azienda Ospedaliero-Universitaria di Bolognacollaborator
- IRCCS National Neurological Institute "C. Mondino" Foundationcollaborator
- I.R.C.C.S. Fondazione Santa Luciacollaborator
- Ospedale Policlinico San Martinocollaborator
- IRCCS San Camillo, Venezia, Italycollaborator
- Istituto Di Ricerche Farmacologiche Mario Negricollaborator
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Bestacollaborator
- Ospedale Pediatrico Bambin Gesùcollaborator
- Fondazione IRCCS Policlinico San Matteo di Paviacollaborator
- IRCCS Fondazione Stella Mariscollaborator
- Istituto Neurologico Mediterraneo Neuromed S. R. Lcollaborator
- IRCCS San Raffaele Romacollaborator
- Ospedale San Raffaelecollaborator
- IRCCS Centro Neurolesi Bonino Pulejocollaborator
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicocollaborator
- Istituto Auxologico Italianocollaborator
- Istituti Clinici Scientifici Maugeri SpAcollaborator
- Fondazione IRCCS San Gerardo dei Tintoricollaborator
Study Sites (1)
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Lazio, 00168, Italy
Related Publications (6)
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990 Apr;21(4):637-76. doi: 10.1161/01.str.21.4.637. No abstract available.
PMID: 2326846RESULTTimmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S; Atlas Writing Group, European Society of Cardiology. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892.
PMID: 35016208RESULTGBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
PMID: 34487721RESULTSacco S, Stracci F, Cerone D, Ricci S, Carolei A. Epidemiology of stroke in Italy. Int J Stroke. 2011 Jun;6(3):219-27. doi: 10.1111/j.1747-4949.2011.00594.x.
PMID: 21557809RESULTOzpinar A, Mendez G, Abla AA. Epidemiology, genetics, pathophysiology, and prognostic classifications of cerebral arteriovenous malformations. Handb Clin Neurol. 2017;143:5-13. doi: 10.1016/B978-0-444-63640-9.00001-1.
PMID: 28552158RESULTFerro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019 Aug 23;19(10):74. doi: 10.1007/s11910-019-0988-x.
PMID: 31440838RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Head of Neurology Department
Study Record Dates
First Submitted
June 9, 2023
First Posted
June 29, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
September 1, 2052
Study Completion (Estimated)
September 1, 2052
Last Updated
July 13, 2023
Record last verified: 2023-07